Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology MFM
- The epidemiology of pelvic floor disorders and childbirth: an update.Obstet Gynecol Clin North Am. 2016; 43: 1-13
- Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050.Am J Obstet Gynecol. 2011; 205 (230.e1–5)
- Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.Obstet Gynecol. 2014; 123: 1201-1206
- Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.Am J Obstet Gynecol. 2005; 192: 795-806
- Association of delivery mode with pelvic floor disorders after childbirth.JAMA. 2018; 320: 2438-2447
- Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth.Obstet Gynecol. 2011; 118: 777-784
- Pushing/bearing down methods for the second stage of labour.Cochrane Database Syst Rev. 2017; 3CD009124
- Delayed versus early pushing in women with epidural analgesia: a systematic review and meta-analysis.BJOG. 2004; 111: 1333-1340
- Effect of immediate vs delayed pushing on rates of spontaneous vaginal delivery among nulliparous women receiving neuraxial analgesia: a randomized clinical trial.JAMA. 2018; 320: 1444-1454
- Pelvic organ support among primiparous women in the first year after childbirth.Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20: 1407-1411
- Effects of oxytocin for induction and augmentation of labor on pelvic floor symptoms and support in the postpartum period.Female Pelvic Med Reconstr Surg. 2021; 27: 289-296
- Postpartum urinary symptoms: prevalence and risk factors.Eur J Obstet Gynecol Reprod Biol. 2002; 103: 179-182
From the Department of Women's Health, Dell School of Medicine, The University of Texas at Austin, Austin, TX (Drs Saucedo, Macones, and Cahill); Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL (Drs Richter and Tita); Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL (Drs Richter and Tita); Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR (Drs Gregory and Caughey); Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, MO (Drs Woolfolk and Lowder); Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Providence, RI (Dr Tuuli); Women and Infants Hospital of Rhode Island, Providence, RI (Dr Tuuli); and Department of Obstetrics and Gynecology, Maternal and Child Health Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (Dr Srinivas).
The authors report no conflict of interest.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development awarded A.G.C. and M.G.T (grant number U01 HD077384).
The National Institutes of Health (NIH) had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript and the decision to submit for publication. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.
This study was registered on ClinicalTrials.gov (NCT02137200; https://clinicaltrials.gov/ct2/show/NCT02137200). The date of registration was on May 13, 2014. The date of initial participant enrollment was on May 19, 2014.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices), will be available per the 2003 NIH Data Sharing Policy. Other documents include the study protocol. Data will be available beginning 9 months and ending 36 months after the parent study is complete. Data will be from investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for individual participant data meta-analysis. Proposals may be submitted up to 36 months after article publication. After 36 months, the data will be available in the data warehouse but without investigator support other than deposited metadata.
This study was presented as a poster at the 42nd annual meeting of the Society for Maternal-Fetal Medicine, held virtually, February 3, 2022.